Washington University in St. Louis, calls the findings "a very powerful piece of support for the idea that an abnormal protein can confer its abnormal configuration onto the host prion protein. " The puzzle the UCSF workers are addressing dates from 1985, when Prusiner's lab and others found that prions, the protein particles found in the brain in neurodegenerative disorders like C]D and kuru in humans, mad cow disease, and scrapie in sheep, are misfolded or "flipped" versions of cellular prion protein (PrP), a normal component of brain cells. tutes of Health Rocky Mountain Laboratories in Hamilton, Montana, Byron Caughey, and their Rocky Mountain colleagues showed that the two prion conformations could be spread to one type of cellular PrP when the proteins were mixed together in a cell-free system. Now, T elling, Prusiner, and their colleagues have extended the work to human prions in a mouse model. They used a strain of transgenic mice carrying a chimeric human/mouse PrP gene that was developed in their lab for susceptibility to human prions. They injected the animals' brains with extracts from the brains of patients who died either from C]D or from fatal familial insomnia (FFI), an inherited disorder caused by a mutation in the PrP gene.
Prusiner and his colleagues knew that the prion proteins causing the two disorders differ in the way they fold because when they are cut with a protein-splitting enzyme, the C]D material gives a 21-kilodalton fragment, while that from the FFI patients yields a 19-kilodalton fragment. The question then was, would the prions produced in mice infected with the human prions yield the same protein fragments as the parent molecules? And indeed, the animals produced PrP fragments matching those of the original inoculants. "Clearly, you can impart two different conformations to the same primary structure," Prusiner says. "We don't know at this point whether we can keep propagating them in these mice. We suspect that we can, and that's the ongoing experiment." He also suspects that many more conformations are possible.
No study involving prions goes undebated, however, and this one is no exception. At the heart of the criticism lies a problem that has dogged prion research since it first began: No one has yet been able to take the definitive step of generating purified prions in a system that would rule out the possible presence of viruses and show that they transmit scrapielike diseases. "The group has taken a relatively crude [brain] extract," says Michael Harrington, who studies nervous system diseases at the California Institute of Technology in Pasadena. "Therefore, it's not defined." The paper, he adds, is evidence that conformational differences yield strains, "but it doesn't confirm it."
To Prusiner and his colleagues, the failure of years of research to turn up a virus is powerful evidence that none is involved in these disorders. But Telling says, "there are people who will go to their graves believing these diseases are caused by viruses." Prusiner concurs: "Some will say that forever, and there's nothing to say to them except that the evidence is overwhelming .... They can think what they want. I can't help them." -Denise Grady
Denise Grady is a free-lance science writer. 
